Presentations | Sutro Biopharma, Inc.

22nd Annual Federation of Clinical Immunology Societies (FOCIS) Meeting 2022– Abstract and Poster Presentation

22nd Annual Federation of Clinical Immunology Societies (FOCIS) Meeting 2022– Abstract and Poster Presentation Abstract Poster Presentation Th42 – Next-generation Immunostimulatory Antibody-drug Conjugate (iADC) Combines Direct Tumor Killing and Innate Immune...

JMP Securities Life Sciences Conference – Presentation

Events, News, Presentations

JMP Securities Life Sciences Conference – Presentation Webcast...

Jefferies Healthcare Conference 2022 – Presentation

Events, News, Presentations

Jefferies Healthcare Conference 2022 – Presentation Webcast...

2022 ASCO Annual Meeting – Abstract

Events, News, Presentations

2022 ASCO Annual Meeting – Abstract Download Abstract Number TPS5622 STRO-002-GM2: A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination with Bevacizumab in...

Sutro Biopharma Participated in a Clinical Trial, “Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19” Published by Frontiers in Immunology

News, Presentations

Sutro Biopharma Participated in a Clinical Trial, “Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19” Published by Frontiers in Immunology Clinical Trial Article Egg-Derived...

Sutro Biopharma to Participate in Upcoming Investor Conferences

Events, News, Presentations, Press Releases

Sutro Biopharma to Participate in Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., June 2, 2022 – Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the...